Fierce BD&L Summit for Life Sciences 2024 | Fierce Life Sciences Events | 11 March 2024 | Hilton San Francisco Financial District, 750 Kearny Street, San Francisco, CA 94108, USA
Venue
Hilton San Francisco Financial District
Hilton San Francisco Financial District, 750 Kearny Street, San Francisco, CA 94108, USA
What is Qwoted?
Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
| Event Date |
Mon Mar 11 PDT - Tue Mar 12 PDT (9 months ago)
In your timezone (EST): Mon Mar 11 3:00am - Tue Mar 12 3:00am |
| Location |
Hilton San Francisco Financial District
750 Kearny Street, San Francisco, CA 94108, USA |
| Region | Americas |
Details
Successfully identify and execute strategic partnerships, licensing, and M&A Deals. The past year has been a challenging time for life sciences deal-making, with biotech capital markets in a state of flux and the economic climate uncertain. Developing a comprehensive business development strategy for the coming year is not only crucial for future success, but it may also be necessary for the very survival of companies in the industry, as the uncertainty and volatility of the market may continue in the months ahead.
Don't miss out on the opportunity to hear the latest trends, share valuable insights, and discover what the future holds in the life sciences industry by securing your pass today to the summit.
Why you should attend:
• Insight gain valuable insight from cross-functional team members responsible for search and evaluation, legal/IP, portfolio management, strategic alliances, business development and licensing.
• Network be in the room with the life sciences industry leaders to forge new connects and take advantage of in-person networking opportunities.
• Inspiration hear the latest deal drivers, deal-making trends and financing options, including the rise SPACs in life sciences, in order to map out a business development strategy with an eye toward the future.
• Knowledge uncover flexible partnership models, licensing deals, M&A opportunities, and innovative deal structures to maximize potential and ensure a successful and profitable collaboration.
Speakers
2024 Speakers
Mark DePristo
Co-founder and CEO, BigHat Biosciences
Jakob DuPont, M.D.
Executive Partner, Private Equity, Sofinnova Investments
Grace Han McMahon
AVP and Head, Pacific BD&L, Merck
Jeannie Karl, PhD, JD
Senior Director, Pharma Partnering, Transactions, Genentech
Angele Maki, Ph.D.
Chief Business Officer, Hummingbird Bioscience
Michael Myers
Associate Vice President, Lilly Research Labs Due Diligence, Eli Lilly and Company
Michael Palladinetti
Global Head of Business Development, SANOFI
Garrett Rhyasen, PhD
Vice President – Search, Evaluation & Transactions, GSK
Sponsors & Partners
2024 Sponsors
PLATINUM SPONSOR:
• ZS
GOLD SPONSOR:
• AlphaSense
SPONSOR:
• Intelligencia AI
SUPPORTER:
• California Life Sciences